Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Invested Capital (2022 - 2026)

Core Laboratories filings provide 5 years of Invested Capital readings, the most recent being $275.1 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 8.35% to $275.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $275.1 million, a 8.35% increase, with the full-year FY2025 number at $266.0 million, up 5.42% from a year prior.
  • Invested Capital hit $275.1 million in Q1 2026 for Core Laboratories, up from $266.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $275.1 million in Q1 2026 to a low of $173.8 million in Q2 2022.
  • Median Invested Capital over the past 5 years was $241.6 million (2024), compared with a mean of $233.7 million.
  • Biggest five-year swings in Invested Capital: rose 26.38% in 2023 and later grew 5.42% in 2025.
  • Core Laboratories' Invested Capital stood at $183.5 million in 2022, then grew by 22.26% to $224.4 million in 2023, then rose by 12.45% to $252.3 million in 2024, then increased by 5.42% to $266.0 million in 2025, then grew by 3.44% to $275.1 million in 2026.
  • The last three reported values for Invested Capital were $275.1 million (Q1 2026), $266.0 million (Q4 2025), and $271.3 million (Q3 2025) per Business Quant data.